Study of Magnesium Levels and Cognitive Function in Adults After Stroke

What this Trial Is About

Researchers are investigating the relationship between magnesium levels in the blood and cognitive function in adult stroke patients. Cognitive impairments such as memory loss, word-finding difficulties, and problems with orientation and perception are common after stroke. This study focuses on understanding whether low magnesium levels contribute to these cognitive issues, comparing different types of stroke and analyzing stroke severity alongside cognitive outcomes. The study includes stroke patients admitted to a stroke unit. Researchers will measure magnesium concentration in the blood and assess stroke severity using scales like the National Institutes of Health Stroke Scale, Scandinavian Stroke Scale, and modified Rankin Scale. Cognitive abilities will be tested within the first three days using the Klner Neuropsychologische Screening and the Mini Mental Status Test. These assessments and measurements will be repeated at 4 weeks, 3 months, and at the end of the study, which may last up to six months or until discharge from the clinic. Participants will undergo multiple evaluations including blood tests for magnesium, stroke severity scales, and cognitive testing over several months. If the patient receives an MRI scan, their attention network will also be measured. Researchers will track changes in magnesium levels and cognition over time, aiming to identify correlations between magnesium concentration, stroke severity, and cognitive function. The study also monitors complications and length of hospital stay to better understand recovery processes.

Magnesium and Cognition After Stroke